Abstract
Dactylitis is considered a hallmark feature of psoriatic arthritis (PsA), but it is found in other spondyloarthropathies, especially reactive arthritis, and other conditions (eg, sarcoidosis, gout, sickle cell disease, and a variety of infections). Dactylitis is dif. cult to define and assess with any level of consensus and consistency in PsA. A new objective measure has been developed to make assessment more uniform for clinical trials. The underlying pathophysiology has also been dif.cult to determine in spondyloarthropathy: synovitis, tenosynovitis, and enthesitis have all been recognized. The pathophysiology in other conditions varies but usually involves soft tissue and sometimes involves bone or joint. In non-spondyloarthropathies, treatment is determined by the underlying cause. Research on dactylitis treatment in PsA suffers from a paucity of trials and inconsistent outcome measurement. The only drug with good evidence of benefit from randomized controlled trials thus far is infliximab.
Similar content being viewed by others
References and Recommended Reading
Rothschild BM, Pingitore C, Eaton M: Dactylitis: implications for clinical practice. Semin Arthritis Rheum 1998, 28:41–47.
Brockbank JE, Stein M, Schentag CT, Gladman DD: Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 2005, 64:188–190.
Petty RE, Southwood TR, Manners P, et al.: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31:390–392.
Padula A, Scarano E, Giasi V, Olivieri I: Juvenile onset isolated HLA-B27-associated dactylitis. Semin Arthritis Rheum 2003, 32:341–342.
Abril A, Cohen MD: Rheumatologic manifestations of sarcoidosis. Curr Opin Rheumatol 2004, 16:51–55.
Stevens MC, Padwick M, Serjeant GR: Observations on the natural history of dactylitis in homozygous sickle cell disease. Clin Pediatr (Phila) 1981, 20:311–317.
Miller ST, Sleeper LA, Pegelow CH, et al.: Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000, 342:83–89.
Gill FM, Sleeper LA, Weiner SJ, et al.: Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995, 86:776–783.
Martini M, Adjrad A, Boudjemaa A: Tuberculous osteomyelitis. A review of 125 cases. Int Orthop 1986, 10:201–207.
Halsey JP, Reeback JS, Barnes CG: A decade of skeletal tuberculosis. Ann Rheum Dis 1982, 41:7–10.
Andronikou S, Smith B: "Spina ventosa"—tuberculous dactylitis. Arch Dis Child 2002, 86:206.
Schwartzenberg JM, Smith DD, Lindsley HB: Bacillus Calmette-Guerin associated arthropathy mimicking undifferentiated spondyloarthropathy. J Rheumatol 1999, 26:933–935.
Bhatty MA, Turner DP, Chamberlain ST: Mycobacterium marinum hand infection: case reports and review of literature. Br J Plast Surg 2000, 53:161–165.
Parras F, Ezpeleta C, Romero J, et al.: Blistering distal dactylitis in an adult. Cutis 1988, 41:127–128.
Benson PM, Solivan G: Group B streptococcal blistering distal dactylitis in an adult diabetic. J Am Acad Dermatol 1987, 17:310–311.
Ozgocmen S, Ardicoglu O, Ozcakar L: Dactylitis in a patient with brucellosis. J Hand Surg [Br] 2001, 26:171–172.
Dubost JJ, Constantin A, Soubrier M, et al.: Does reactive arthritis caused by Brucella exist? Apropos of 4 cases [in French]. Presse Med 1997, 26:207–210.
Olivieri I, Barozzi L, Favaro L, et al.: Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum 1996, 39:1524–1528.
Olivieri I, Barozzi L, Pierro A, et al.: Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. J Rheumatol 1997, 24:926–930.
Padula A, Salvarani C, Barozzi L, et al.: Dactylitis also involving the synovial sheaths in the palm of the hand: two more cases studied by magnetic resonance imaging. Ann Rheum Dis 1998, 57:61–62.
Olivieri I, Scarano E, Padula A, Giasi V: Dactylitis involving most of the fingers. Clin Exp Rheumatol 2003, 21:406.
Olivieri I, Scarano E, Padula A, Giasi V: Dactylitis of the thumb extending to the radial bursa. J Rheumatol 2003, 30:1626–1627.
Olivieri I, Salvarani C, Cantini F, et al.: Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum 2002, 46:2964–2967.
Kane D, Greaney T, Bresnihan B, et al.: Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol 1999, 26:1746–1751.
McGonagle D, Gibbon W, and Emery P: Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352:1137–1140.
Benjamin M, Moriggl B, Brenner E, et al.: The "enthesis organ" concept: why enthesopathies may not present as focal insertional disorders. Arthritis Rheum 2004, 50:3306–3313.
McGonagle D, Conaghan PG, Emery P: Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999, 42:1080–1086.
Lories RJ, Matthys P, de Vlam K, et al.: Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis 2004, 63:595–598.
Bennett OM: Salmonella osteomyelitis and the hand-foot syndrome in sickle cell disease. J Pediatr Orthop 1992, 12:534–538.
Vanmarsenille JM, de BergB, Houssiau FA, de SelysJ: Unusually prolonged course of tuberculous dactylitis with osteitis. Joint Bone Spine 2003, 70:535–537.
Sunderamoorthy D, Gupta V, Bleetman A: TB or not TB: an unusual sore.nger. Emerg Med J 2001, 18:490–491.
Rodriguez-Gomez M, Fernandez-Sueiro JL, Willisch A, et al.: Multifocal dactylitis as the sole clinical expression of sarcoidosis. J Rheumatol 2000, 27:245–247.
Clegg DO, Reda DJ, Mejias E, et al.: Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996, 39:2013–2020.
Salvarani C, Cantini F, Olivieri I, et al.: Efficacy of infliximab in resistant psoriatic arthritis. Arthritis Rheum 2003, 49:541–545.
Kaltwasser JP, Nash P, Gladman D, et al.: Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2004, 50:1939–1950.
Antoni CE, Kavanaugh A, Kirkham B, et al.: Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum 2005, 52:1227–1236. [Published erratum appears in Arthritis Rheum 2005, 52:2951.]
Antoni C, Krueger GG, de Vlam K, et al.: Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005, 64:1150–1157.
Helliwell PS, Firth J, Ibrahim GH, et al.: Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005, 32:1745–1750. Charts the development and testing of a new objective dactylitis tool.
Helliwell PS: Therapies for dactylitis in psoriatic arthritis. A systematic review. J Rheumatol 2006, In press. A comprehensive review of therapy for dactylitis.
Salvarani C, Macchioni P, Olivieri I, et al.: A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol 2001, 28:2274–2282.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Healy, P.J., Helliwell, P.S. Dactylitis: Pathogenesis and clinical considerations. Curr Rheumatol Rep 8, 338–341 (2006). https://doi.org/10.1007/s11926-006-0062-y
Issue Date:
DOI: https://doi.org/10.1007/s11926-006-0062-y